Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine adipate
(S)-(+)-β-phenylisopropylamine
Dextroamphetamine saccharate
(S)-α-methylbenzeneethanamine
(+)-α-methylphenylethylamine
(αS)-α-methylbenzeneethanamine
Dexamfetaminum
(S)-amphetamine
Desamfetamina
Dexamphetamine
Dexamfetamina
d-amphetamine
Dexamfetamine
Dextroamphetamine
(S)-1-phenyl-2-aminopropane
(+)-(S)-amphetamine
(+)-amphetamine
(S)-1-phenyl-2-propylamine
(S)-(+)-amphetamine
Dextroamphetamine sulfate
(+)-α-methylphenethylamine
Dexanfetamina
Brand Names
Dexedrine
Zenzedi
Dexedrine Spansule
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
